Solv Series C equity financing
Primary Investment02/09/2021
Solv announced the close of Series C financing led by Acrew Capital and Corner Ventures, with prior investors Greylock and Benchmark participating. Proceeds were intended to expand the healthcare-provider network, consumer services and cost-transparency capabilities.
Type
Primary Investment
Announced
02/09/2021
Amount
Financial data requires access
Asset class
Venture Capital
Reported parties
Solv Health, Inc.,Acrew Capital,Corner Ventures,Greylock Management Corporation,Benchmark